Medical device manufacturer maintains fast growth driven by innovation

A workshop of Hangzhou Kangji Medical Instrument Co Ltd based in Tonglu county, East China's Zhejiang province. [Photo provided to chinadaily.com.cn]

Hangzhou Kangji Medical Instrument Co Ltd maintained robust growth momentum in 2021 despite the unstable global supply chain caused by the COVID-19 pandemic.

Headquartered in Tonglu county, East China's Zhejiang province, Kangji is a medical device company mainly engaged in the R&D, manufacture and commercialization of laparoscopic surgical instruments. 

In June 2020, Kangji made its initial public offerings on the Hong Kong Stock Exchange.

The company was among the top 10 enterprises in Tonglu in terms of industrial tax payments in 2021. It was also conferred with the Hangzhou Government Quality Award that year.

Shentu Yinguang, vice chairman of Kangji, attributed the company's success to its long-term devotion to technological innovation.

The company's laparoscopic surgical instruments have been widely used by well-known large and medium-sized medical institutions such as Peking Union Medical College Hospital. 

In addition, other medical devices developed by Kangji, including a multi-functional casing puncture device, disposable ligation clip and disposable electric coagulation cutting instrument, are leading the nation.

The company now boasts 19 valid invention patents, with more expected to be applied for.